Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by 최성원, Executive. Officer active across 2 companies, notably 광동제약. In total, 48 reports have been recorded. Activity tracked since 27 February 2026. The latest transaction was filed on 27 February 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Choi Sung-won is an Executive at Kwangdong Pharmaceutical, a pharmaceutical company. He contributes to strategic direction and operational optimization. Choi Sung-won is committed to promoting innovation and efficiency within the organization. His role is essential for maintaining Kwangdong Pharmaceutical's competitiveness in the market.